ADMA – adma biologics inc (US:NASDAQ)
Stock Stats
News
2/5
07:23 am
adma
Medium
Assessing ADMA Biologics (ADMA) Valuation After Growing Analyst Optimism On Earnings And Plasma Therapy Pipeline [Yahoo! Finance]
2/5
04:43 am
adma
Medium
Is ADMA Biologics (ADMA) Pricing Reflect A Potential Gap To DCF And P/E Estimates [Yahoo! Finance]
2/2
07:36 pm
adma
Low
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]
1/22
10:31 am
adma
Low
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? [Yahoo! Finance]
1/21
04:13 am
adma
Low
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]
11/5/2025
04:05 pm
adma
-8.7%
MISS
8/6/2025
04:05 pm
adma
-8.2%
IN-LINE
5/7/2025
04:05 pm
adma
-11.5%
MISS
3/3/2025
04:00 pm
adma
7.5%
BEAT
1/12
08:21 am
adma
Low
Form 8-K ADMA BIOLOGICS, INC. For: Jan 12
12/16
09:00 pm
adma
Low
Form 4 ADMA BIOLOGICS, INC. For: Dec 15 Filed by: Grossman Adam S
11/21
09:01 pm
adma
Medium
Form 4 ADMA BIOLOGICS, INC. For: Nov 19 Filed by: Grossman Adam S
Show more
Top News Gainers
3/20 Form 8-K ADMA BIOLOGICS, INC. For: Mar 20 36.6%
1/9 ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook 17.6%
3/3 Form 4 ADMA BIOLOGICS, INC. For: Feb 28 Filed by: Grossman Adam S 10.8%
3/10 Form SEC STAFF LETTER ADMA BIOLOGICS, INC. 8.6%
5/21 ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 8.5%
8/23 Form 8-K ADMA BIOLOGICS, INC. For: Aug 23 7.7%
9/5 Form 8-K ADMA BIOLOGICS, INC. For: Aug 29 7.3%
5/8 Q1/2019 3/31/2019 EPS -0.280 ZacksConsensus -0.320 ActVsEst 0.040 - Beat 7.3%
7/8 Form 8-K ADMA BIOLOGICS, INC. For: Jul 02 6.9%
10/21 ADMA Biologics Announces First Commercial Sales of ASCENIV™ 6.5%
Top News Decliners
2/6 ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock -14.3%
6/6 Form 8-K ADMA BIOLOGICS, INC. For: Jun 06 -12.3%
10/2 Form 8-K ADMA BIOLOGICS, INC. For: Oct 02 -11.2%
11/6 Form 8-K ADMA BIOLOGICS, INC. For: Nov 06 -10.5%
3/5 ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 -10.4%
3/3 New U.S. patent lifts Adma Biologics, up 17% premarket [Seeking Alpha] -9.9%
3/16 ADMA Biologics Inc (NASDAQ: ADMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $14.00. -9.1%
10/3 Form 8-K ADMA BIOLOGICS, INC. For: Oct 03 -8.5%
3/9 Form SC 13G/A ADMA BIOLOGICS, INC. Filed by: BlackRock Inc. -7.5%
12/3 ADMA Biologics Inc (NASDAQ: ADMA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -7.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3